Abstract
Sleep disturbances due to medications is a common problem. The effects can vary from mild insomnia to major alterations in sleep architecture. The factors affecting the sleep disturbances can be related to the patient or the drug. In this review article we have focused on the side effects due to medication commonly used in pulmonary medicine. The group of drugs discussed are corticosteroids, bronchodilators, leukotriene antagonists, methylxanthines, antihistamines, immunosuppressive medications and prostaglandins. Most evidence comes from studies involving small number of healthy volunteers, retrospective reports, or sleep disturbance reported during clinical trials. Though most of these medications have the potential to cause sleep disturbances, they may actually promote better sleep by improving the respiratory symptoms, especially in asthmatics and COPD patients. It is important that the clinician needs to be aware of these side effects so that the effects can be minimized by making appropriate adjustments to the drugs, making the patient aware of the side effects, counseling on good sleep hygiene and behavioral changes.
Keywords: Insomnia, sleep disturbances, medications, drugs, pulmonary drugs
Current Respiratory Medicine Reviews
Title: Sleep Disturbances Due to Pulmonary Medications
Volume: 5 Issue: 4
Author(s): Raghu M. Reddy and Shyamsunder Subramanian
Affiliation:
Keywords: Insomnia, sleep disturbances, medications, drugs, pulmonary drugs
Abstract: Sleep disturbances due to medications is a common problem. The effects can vary from mild insomnia to major alterations in sleep architecture. The factors affecting the sleep disturbances can be related to the patient or the drug. In this review article we have focused on the side effects due to medication commonly used in pulmonary medicine. The group of drugs discussed are corticosteroids, bronchodilators, leukotriene antagonists, methylxanthines, antihistamines, immunosuppressive medications and prostaglandins. Most evidence comes from studies involving small number of healthy volunteers, retrospective reports, or sleep disturbance reported during clinical trials. Though most of these medications have the potential to cause sleep disturbances, they may actually promote better sleep by improving the respiratory symptoms, especially in asthmatics and COPD patients. It is important that the clinician needs to be aware of these side effects so that the effects can be minimized by making appropriate adjustments to the drugs, making the patient aware of the side effects, counseling on good sleep hygiene and behavioral changes.
Export Options
About this article
Cite this article as:
Reddy M. Raghu and Subramanian Shyamsunder, Sleep Disturbances Due to Pulmonary Medications, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112393
DOI https://dx.doi.org/10.2174/157339809790112393 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of a Triggered Nocturnal Blood Pressure Monitoring which Detects Nighttime Blood Pressure Surges in Sleep Apnea Syndrome
Current Hypertension Reviews Treating Cancer in Older and Oldest Old Patients
Current Pharmaceutical Design Prognostic Parameters for Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in an Asian Population
Current Neurovascular Research Mechanisms, Prevention and Treatment of Distal Embolization
Current Pharmaceutical Design Hemolytic Uremic Syndrome in Children
Current Pediatric Reviews Anti-Angiogenic Therapies for Children with Cancer
Current Cancer Drug Targets The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
Current Drug Targets Copeptin in Preeclampsia Development
Current Women`s Health Reviews Molecular Hydrogen: New Antioxidant and Anti-inflammatory Therapy for Rheumatoid Arthritis and Related Diseases
Current Pharmaceutical Design Prevalence and Clinical Profile of Undiagnosed Diabetes Mellitus: Data from a Tertiary Hospital
Endocrine, Metabolic & Immune Disorders - Drug Targets Selective Cyclooxygenase Inhibitors: Current Status
Current Drug Discovery Technologies Postoperative Delirium
Current Drug Targets The Therapeutic use of the Zonulin Inhibitor AT-1001 (Larazotide) for a Variety of Acute and Chronic Inflammatory Diseases
Current Medicinal Chemistry Optimal Management of Hypertension in patients with Ischemic Heart Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Preoperative Plasma Aldosterone Levels and Postoperative Atrial Fibrillation Occurrence Following Cardiac Surgery: A Review of Literature and Design of the ALDO-POAF Study (ALDOsterone for Prediction of Post-Operative Atrial Fibrillation)
Current Clinical Pharmacology A Novel Design of Combining the Angiotensin Converting Enzyme (ACE) Inhibitor Captopril with the Angiotensin Receptor Blocker (ARB) Losartan Using Homo Coupling via PEG Diacid Linker
Recent Patents on Cardiovascular Drug Discovery Serum Amyloid A and Its Potential Physiological / Pathological Functions - an Overview of Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Antihypertensive Therapy in Patients Receiving Maintenance Hemodialysis: A Narrative Review of the Available Clinical-Trial Evidence
Current Vascular Pharmacology Prevention and Management of Hypertension Without Drugs
Current Hypertension Reviews Chest Pain in Children
Current Pediatric Reviews